Skip to main content
padlock icon - secure page this page is secure

Resveratrol protects against experimental induced Reye’s syndrome by prohibition of oxidative stress and restoration of complex I activity

Buy Article:

$36.73 + tax (Refund Policy)

This study was designed to investigate whether resveratrol could provide protection against Reye’s syndrome induced by 4-pentenoic acid in Wistar albino rats. Compared with rats with untreated Reye’s syndrome, 1 h pretreatment by low dose resveratrol (10 mg/kg by oral gavage) resulted in marked amelioration in liver functions in the form of significant decrease in serum transaminases (AST, ALT) and plasma ammonia levels, shortening of prothrombin time, and increase in serum albumin levels. In addition, resveratrol prohibited oxidative stress markers, as indicated by a significant increase in GSH and decrease in MDA, with restoration of complex I activity in liver tissues. The classical histopathological presentation in Reye’s syndrome of microvesicular steatosis by light microscope and mitochondria distortion by electron microscope has been improved by resveratrol pretreatment. The efficient protection by resveratrol was determined by normalization in serum levels of AST and albumin, as well as complex I activity, GSH, and MDA. In conclusion, pretreatment by resveratrol in low doses could protect against Reye’s syndrome partially via prohibition of oxidative stress and restoration of complex I activity. This may provide the opportunity to reconsider aspirin therapy for infants and young children. However, the verification of such results in clinical practice remains a challenge.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Reye’s syndrome; antioxidant; antioxydant; aspirin; aspirine; dysfonction mitochondriale; dérivé du stilbène; mitochondrial dysfunction; stilbene derivative; syndrome de Reye

Document Type: Research Article

Affiliations: 1: Department of Pharmacology, Faculty of Medicine, Tanta University, Al-Geish Street, Postal No. 31527, Egypt. 2: Department of Histology, Faculty of Medicine, Tanta University, Egypt.

Publication date: January 1, 2014

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more